ApiJect is a medical technology company that is reimagining how injectable drugs are packaged and delivered to the world. The ApiJect Technology Platform brings together Blow-Fill-Seal (BFS) aseptic drug packaging technology with interlocking components, ApiJect is able to help pharmaceutical companies more efficiently and aseptically package their drug products in single-dose prefilled injectors. 

ApiJect makes putting drug products in BFS as easy and affordable as possible. Whether the pharmaceutical company chooses to do the BFS drug packaging at their own facilities, at a trusted CMO, or in ApiJect’s factories, ApiJect is there to make the manufacturing process as turn-key as possible. 

Designed for vaccine and COVID-19 response, ApiJect’s first single-dose Prefilled Injector is designed for a 0.2mL - 2.1mL dose fill. And thanks to the flexibility of BFS, future ApiJect injectors will make it so nearly any injectable drug can be packaged and delivered through our platform.

Sales Markets

Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Meet us at

CPhI Festival of Pharma

5 - 16 October 2020

View Our Exhibitor Profile

Contact information




View All Contact Info